Australia’s medical cannabis market is predicted to exceed USD 2.67 billion by 2035, according to a recent Market.us Media report.
The market was worth an estimated $781.6 million in 2025 and is expected to grow at a Compound Annual Growth Rate of 13.1% over the next 10 years.
The medical cannabis program is regulated by the Therapeutic Goods Administration (TGA). Patients have access to many different types of products, including cannabis flower, oils, capsules, and oral sprays, with cannabinoid content primarily of tetrahydrocannabinol (THC or cannabidiol (CBD).
Hemp-based products dominate the market with a 54.1% share, according to the report, due to greater regulatory flexibility and commercial acceptance.
The report cited growing patient awareness and acceptance among healthcare professionals, new research, and improved product availability as major market growth contributors.
Ganjapreneur: Offering daily insights since 2014, the leading digital business journal for cannabis industry professionals. Subscribe to the newsletter to join our community of over 40,000 ganjapreneurs.
